Standard BioTools Inc. (NASDAQ: LAB), a key player in the healthcare sector’s medical devices industry, is a company that demands the attention of savvy investors. With a market capitalization of..
Cel-Sci Corporation (NASDAQ: CVM) is capturing investor attention with its ambitious approach to cancer treatment and a staggering potential upside of 751.70%, according to analyst ratings. This clinical-stage biotechnology company,..
Rapport Therapeutics, Inc. (RAPP), a clinical-stage biopharmaceutical company based in Boston, Massachusetts, is making waves in the biotechnology sector with its promising pipeline focused on central nervous system (CNS) disorders...
Simulations Plus, Inc. (NASDAQ: SLP), a prominent player in the healthcare sector, is making waves with its cutting-edge drug discovery and development software. Renowned for its use of artificial intelligence..
Oruka Therapeutics, Inc. (NASDAQ: ORKA) is drawing significant attention from investors with its promising pipeline in the biotechnology sector. Specializing in the development of monoclonal antibody therapeutics for psoriasis and..
Surmodics, Inc. (NASDAQ: SRDX) stands at the intersection of innovation and challenge within the medical devices sector. With a focus on performance coating technologies for intravascular devices and chemical components..
AngioDynamics, Inc. (NASDAQ: ANGO), a prominent player in the healthcare sector, specializes in the design and manufacture of medical instruments and supplies, particularly for treating peripheral vascular diseases and oncology...
LifeMD, Inc. (NASDAQ: LFMD), a burgeoning player in the healthcare sector, is carving a niche in the rapidly expanding telehealth industry. With a market capitalization of $181.47 million, this New..
Precigen, Inc. (NASDAQ: PGEN) is garnering attention in the biotechnology sector with a striking potential upside of over 100%. As a discovery and clinical-stage biopharmaceutical company, Precigen is making waves..
Prothena Corporation plc (NASDAQ: PRTA), an Irish biotechnology firm, has captured the attention of investors with its robust product pipeline targeting diseases caused by protein dysregulation. With a current market..
Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a prominent player in the biotechnology sector, is drawing significant attention from investors due to its potential upside of 276.13%. This San Carlos, California-based company..
Investors seeking opportunities in the healthcare sector might find Auna SA (AUNA) an intriguing prospect, as its current market dynamics present a significant potential upside. Operating within the medical care..
OrthoPediatrics Corp. (NASDAQ: KIDS), a prominent player in the healthcare sector, is carving a niche in the medical devices industry by focusing on pediatric orthopedics. Headquartered in Warsaw, Indiana, this..
Semler Scientific, Inc. (NASDAQ: SMLR), a player in the healthcare sector specializing in medical devices, presents an intriguing opportunity for investors with its remarkable potential upside of 223%. This California-based..
Castle Biosciences, Inc. (NASDAQ: CSTL) is making waves in the healthcare sector, particularly in the diagnostics and research industry. With a market capitalization of $1.19 billion, this molecular diagnostics company..
Organogenesis Holdings Inc. (NASDAQ: ORGO), a key player in the regenerative medicine sector, is drawing attention from investors with its significant potential upside of 114.11%. Specializing in advanced wound care..
Septerna, Inc. (SEPN), a dynamic player in the biotechnology sector, is gaining attention from investors seeking high-growth opportunities in the healthcare industry. Founded in 2019 and headquartered in South San..
For investors with a keen eye on the biotechnology sector, Celcuity Inc. (NASDAQ: CELC) presents an intriguing opportunity. With a market capitalization of $4.87 billion, this clinical-stage biotech firm is..
Oric Pharmaceuticals, Inc. (NASDAQ: ORIC) is gaining attention in the biotech sector, not only because of its innovative approach to tackling cancer resistance mechanisms but also due to its significant..
Verastem, Inc. (NASDAQ: VSTM) has emerged as a biotech company capturing attention with its promising pipeline and significant upside potential. With its current market capitalization of $497.11 million, Verastem focuses..
